RISANKIZUMAB-RZAA for Crohn's disease: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 12,561 adverse event reports in the FDA FAERS database where RISANKIZUMAB-RZAA was used for Crohn's disease.
Most Reported Side Effects for RISANKIZUMAB-RZAA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Psoriasis | 6,896 | 10.5% | 12 | 778 |
| Drug ineffective | 2,885 | 4.4% | 6 | 379 |
| Pain | 2,584 | 4.0% | 18 | 571 |
| Fatigue | 2,483 | 3.8% | 4 | 446 |
| Arthralgia | 2,419 | 3.7% | 7 | 419 |
| Pruritus | 2,311 | 3.5% | 2 | 213 |
| Covid-19 | 2,145 | 3.3% | 55 | 640 |
| Death | 1,700 | 2.6% | 1,637 | 80 |
| Fall | 1,666 | 2.6% | 32 | 782 |
| Surgery | 1,662 | 2.5% | 5 | 245 |
| Headache | 1,554 | 2.4% | 5 | 239 |
| Diarrhoea | 1,427 | 2.2% | 7 | 475 |
| Crohn's disease | 1,338 | 2.1% | 12 | 685 |
| Device issue | 1,245 | 1.9% | 1 | 168 |
| Rash | 1,188 | 1.8% | 2 | 148 |
Other Indications for RISANKIZUMAB-RZAA
Psoriasis (40,890)
Product used for unknown indication (7,604)
Psoriatic arthropathy (6,970)
Colitis ulcerative (786)
Rheumatoid arthritis (252)
Illness (79)
Hidradenitis (65)
Maternal exposure timing unspecified (65)
Guttate psoriasis (64)
Arthritis (57)
Other Drugs Used for Crohn's disease
ADALIMUMAB (99,540)
INFLIXIMAB (40,796)
VEDOLIZUMAB (28,718)
USTEKINUMAB (22,537)
INFLIXIMAB-DYYB (10,657)
HUMIRA (10,174)
CERTOLIZUMAB PEGOL (8,758)
UPADACITINIB (4,390)
MESALAMINE (2,930)
AZATHIOPRINE (2,823)